- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-1-2-1-1-1-1-1-1-1-1-1-2-1-1-1-mer
- Ligands
- 2 x FES: FE2/S2 (INORGANIC) CLUSTER(Non-covalent)
- 6 x SF4: IRON/SULFUR CLUSTER(Non-covalent)
SF4.2: 15 residues within 4Å:- Chain A: H.138, S.139, D.141, C.142, C.145, Q.147, G.148, C.151, L.153, Q.154, R.191, V.251, G.252
- Chain n: M.307, I.311
4 PLIP interactions:4 interactions with chain A,- Metal complexes: A:H.138, A:C.142, A:C.145, A:C.151
SF4.3: 15 residues within 4Å:- Chain A: M.189, C.192, I.193, H.194, C.195, T.196, K.197, C.198, I.224, I.248, C.249, P.250, V.251, A.253, L.254
4 PLIP interactions:4 interactions with chain A,- Metal complexes: A:C.192, A:C.195, A:C.198, A:C.249
SF4.57: 13 residues within 4Å:- Chain n: R.71, H.156
- Chain s: A.85, C.86, C.87, G.122, T.123, G.149, S.150, C.151, Y.158, C.181, P.182
4 PLIP interactions:4 interactions with chain s,- Metal complexes: s:C.86, s:C.87, s:C.151, s:C.181
SF4.58: 16 residues within 4Å:- Chain t: H.92, T.113, C.114, P.115, A.116, A.118, I.119, L.138, C.143, I.144, Y.145, C.146, G.147, L.148, C.149, E.160
6 PLIP interactions:6 interactions with chain t,- Salt bridges: t:E.160
- Metal complexes: t:H.92, t:C.114, t:C.143, t:C.146, t:C.149
SF4.59: 15 residues within 4Å:- Chain t: L.94, C.104, I.105, T.106, C.107, Q.108, L.109, C.110, I.121, F.136, C.153, P.154, V.155, A.157, I.158
4 PLIP interactions:4 interactions with chain t,- Metal complexes: t:C.104, t:C.107, t:C.110, t:C.153
SF4.61: 14 residues within 4Å:- Chain w: I.206, P.224, S.379, C.380, N.381, Q.382, C.383, C.386, R.387, S.424, I.425, C.426, L.428, G.429
4 PLIP interactions:4 interactions with chain w,- Metal complexes: w:C.380, w:C.383, w:C.386, w:C.426
- 1 x K: POTASSIUM ION(Non-covalent)
- 26 x PC1: 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
PC1.5: 19 residues within 4Å:- Chain E: R.78, P.79, S.82, P.86, L.87, V.89, V.90, Y.91, Y.118
- Ligands: PC1.6
- Chain h: I.362, Y.363, I.365, L.366, L.369
- Chain u: X.7, X.8, X.9, X.10
Ligand excluded by PLIPPC1.6: 17 residues within 4Å:- Chain 7: L.329
- Chain E: R.78, V.90, Q.108, S.109, F.110, R.113, G.114, L.115, S.116
- Chain L: F.488, P.489
- Ligands: PC1.5
- Chain h: S.361, I.362, Y.363
- Chain u: X.6
Ligand excluded by PLIPPC1.9: 17 residues within 4Å:- Chain L: Y.464, D.465, K.466, K.467, L.468, I.469, A.470, F.471, V.474
- Chain m: L.34, F.95, N.97, N.98, K.99, Q.102, L.103, I.106
Ligand excluded by PLIPPC1.10: 8 residues within 4Å:- Chain L: N.301, W.302, P.303, I.304, S.306, N.308, H.373, R.375
Ligand excluded by PLIPPC1.13: 31 residues within 4Å:- Chain E: G.3, G.4, G.5, G.6, W.7, S.8, V.11, P.12, I.15, L.16, V.19
- Chain O: P.69, E.73, R.76, F.77, F.80, L.97, L.100, V.101, L.104, Y.112, E.113, Y.116
- Ligands: CDL.15, CDL.16
- Chain h: W.404, F.405, L.407
- Chain t: F.68, R.69, P.71
Ligand excluded by PLIPPC1.20: 28 residues within 4Å:- Chain G: A.65, V.66, G.69, Y.70, V.73, A.74, Y.77, E.78, R.84
- Chain K: A.202, H.203, G.204, Q.205, F.206, Y.207
- Chain P: L.68, L.71, Y.72, R.75, V.76, A.79, F.80, D.83
- Ligands: CDL.19
- Chain h: L.668, L.669
- Chain j: L.265, Y.269
Ligand excluded by PLIPPC1.21: 31 residues within 4Å:- Chain 5: W.194, Y.335
- Chain P: G.51, K.52, G.53, V.54, S.55, M.56, A.59, I.63
- Ligands: CDL.17, CDL.18, PC1.41, PC1.42
- Chain e: Y.426
- Chain h: L.549, P.553, L.554, L.556, Y.557, I.560, I.635, I.638, I.639
- Chain t: L.52, K.54, M.57, K.58, M.60, W.61, T.64
Ligand excluded by PLIPPC1.22: 31 residues within 4Å:- Chain Q: W.6, Q.7, I.9, L.10, V.81, Q.85, V.128, V.162, T.165, A.166, Y.169, H.173, N.175, R.177, F.194, L.195, S.196, G.197, I.198, V.199, G.200, L.203
- Ligands: 3PE.23
- Chain i: Y.223, Y.226, I.227
- Chain l: F.566, Y.570, L.571, N.575, F.579
Ligand excluded by PLIPPC1.26: 27 residues within 4Å:- Chain 0: M.62, V.65, W.66, T.69, L.70, I.73
- Chain U: T.47, S.51, W.55, R.58
- Chain V: L.44, H.48
- Chain Z: P.34, A.35, F.36, K.37
- Ligands: CDL.25, PC1.27, PC1.50, PC1.53
- Chain k: I.457, I.461, L.465, F.468, L.470
- Chain l: I.14, L.18
Ligand excluded by PLIPPC1.27: 32 residues within 4Å:- Chain 0: R.46, P.47, T.48, W.50, I.55, W.56, A.58, V.59, L.60, M.62, F.63, W.66
- Chain U: V.28, L.31, M.32, R.33, L.35, A.36, X.37, X.38, X.39, X.42, W.43, V.46, T.47, A.50
- Chain Y: F.141
- Ligands: CDL.25, PC1.26, PC1.47
- Chain k: F.450, I.454
Ligand excluded by PLIPPC1.29: 11 residues within 4Å:- Chain 1: I.90, F.94, W.107
- Ligands: CDL.28
- Chain f: T.8, R.11, L.12
- Chain k: I.18, M.22, K.23, M.24
Ligand excluded by PLIPPC1.31: 36 residues within 4Å:- Chain 5: G.78, D.79, G.80, L.81, L.82, R.83, P.151, P.222, L.223, V.224, S.228, P.229, A.230, L.231, F.234, Y.237, M.238, A.241, Y.244, P.245, V.247, I.253, H.289, F.292, I.293, V.296, G.314, I.317, V.318, L.321, L.328, V.329, M.333, V.334, I.337, I.342
Ligand excluded by PLIPPC1.33: 30 residues within 4Å:- Chain 8: F.91, L.92, M.93, K.95, F.96, V.97, K.99, G.100, L.101, R.142, Y.147
- Chain T: L.131, F.134
- Ligands: PC1.34, CDL.51, 3PE.54
- Chain k: L.410, I.413, F.414
- Chain l: F.181, L.219, I.220, M.223, W.230, S.281, L.282, I.284, L.285, I.415, Y.416
Ligand excluded by PLIPPC1.34: 20 residues within 4Å:- Chain 8: Y.87, L.90, M.93, D.94, V.97, S.98, L.102, D.103, S.107, Y.109, L.114, Y.115, K.117, A.118, C.121, L.122
- Chain T: W.141, A.142
- Ligands: PC1.33, CDL.51
Ligand excluded by PLIPPC1.35: 7 residues within 4Å:- Chain 8: S.181, G.182, F.183, V.184, W.205
- Ligands: PC1.36, CDL.51
Ligand excluded by PLIPPC1.36: 11 residues within 4Å:- Chain 8: Y.115, E.116, L.123, S.149, W.153, R.158, F.183, W.186
- Chain X: N.113
- Ligands: PC1.35, CDL.51
Ligand excluded by PLIPPC1.39: 30 residues within 4Å:- Chain V: W.23, R.24, T.27, F.28, S.31, C.32, L.35
- Chain c: V.82, K.83, K.84, L.85, E.86, R.87, G.88, Q.89, V.90, I.91, A.94, V.95, T.98, L.101, W.102, V.105, A.106
- Chain l: Y.30, M.33, L.34, I.35, V.37, I.41
Ligand excluded by PLIPPC1.41: 35 residues within 4Å:- Chain G: L.51, M.52, P.54, A.55
- Ligands: CDL.7, PC1.21
- Chain e: P.420, V.421, F.422
- Chain h: Y.557, I.558, I.560, F.561, L.564, P.571, I.639, L.643, F.646, N.650, N.653, L.654, Y.657, Y.658, I.659, F.662
- Chain n: N.199, I.200, E.203
- Chain t: F.47, Q.50, F.51, L.53, I.56, M.57, M.60
Ligand excluded by PLIPPC1.42: 11 residues within 4Å:- Ligands: PC1.21
- Chain h: I.547, L.549, L.556, F.617, Y.620, I.624, I.627, H.628, I.631, I.635
Ligand excluded by PLIPPC1.43: 21 residues within 4Å:- Chain C: L.79, I.82, I.83, V.86
- Chain Q: F.2, Q.3, P.4, V.5, W.182
- Chain X: L.52, V.55
- Chain d: H.203, R.204, K.207
- Chain i: L.225, I.229, F.230, L.234, F.235
- Chain k: I.155, I.158
Ligand excluded by PLIPPC1.44: 27 residues within 4Å:- Chain E: L.106
- Chain L: A.478, A.479, L.481, Y.482, A.485
- Chain P: W.160, N.162
- Chain h: I.459, N.460, I.461
- Chain j: N.172, V.173, I.174, N.175, I.178
- Chain m: L.20, I.21, I.24, I.27, I.28, I.31, I.53, I.57, I.60, N.61, I.72
Ligand excluded by PLIPPC1.46: 21 residues within 4Å:- Chain C: X.133, X.134, X.137, X.138, X.141
- Ligands: CDL.45
- Chain k: Y.3, I.7, Y.10, I.11, L.14, I.15, I.18, I.53, N.54, I.55, Y.56, I.58, I.66, L.68, I.113
Ligand excluded by PLIPPC1.47: 13 residues within 4Å:- Chain 0: T.52, W.56, L.60, F.63
- Chain U: T.25, G.26, V.27
- Ligands: PC1.27
- Chain k: Y.29, R.30, S.33, I.34, I.37
Ligand excluded by PLIPPC1.50: 36 residues within 4Å:- Chain V: D.12, F.13
- Ligands: CDL.25, PC1.26, PC1.53
- Chain k: N.367, S.372, Y.373, Y.375, F.376, L.379, L.380, L.390, F.434, Y.435, T.436, I.464, F.468
- Chain l: L.10, I.14, N.17, L.18, K.112, N.113, R.116, I.120, L.123, Y.126, N.127, L.130, M.139, I.142, M.146, L.153, N.159, N.160
Ligand excluded by PLIPPC1.52: 23 residues within 4Å:- Chain V: R.57, P.60, Y.64, M.82, F.86
- Chain c: W.102, V.103, A.106, G.107, S.110, K.111, N.113, N.114
- Chain l: I.41, I.42, W.44, Y.45, L.47, Y.48, I.51, L.484, L.485, I.488
Ligand excluded by PLIPPC1.53: 19 residues within 4Å:- Chain V: L.44, H.48
- Chain Z: R.32, K.37
- Ligands: PC1.26, PC1.50
- Chain k: F.468, N.469, L.470
- Chain l: I.3, L.64, S.65, Y.66, N.67, L.78, I.80, Y.126, L.130, M.139
Ligand excluded by PLIP- 18 x CDL: CARDIOLIPIN(Non-covalent)
CDL.7: 25 residues within 4Å:- Chain 9: G.31, K.32, W.33, G.34, W.36, M.73
- Chain G: T.44, F.46, R.47, M.50, L.51, A.55, H.58, L.61
- Ligands: CDL.38, PC1.41
- Chain i: L.26, N.28
- Chain t: G.40, L.41, M.43, G.44, F.47, M.48, F.51
Ligand excluded by PLIPCDL.14: 13 residues within 4Å:- Chain E: W.7, V.11
- Chain J: H.17, I.20, Q.21, W.24
- Chain O: P.68, G.72, E.73, F.74, R.78
- Chain t: F.68, R.69
Ligand excluded by PLIPCDL.15: 16 residues within 4Å:- Chain O: R.94, R.98, V.101, R.102, R.105, T.106, G.150, S.151, F.153, T.154
- Ligands: PC1.13, CDL.16
- Chain h: W.404
- Chain s: W.9, P.11, Y.12
Ligand excluded by PLIPCDL.16: 27 residues within 4Å:- Chain E: L.16, V.20, L.24
- Chain O: R.105, R.108, F.153
- Ligands: PC1.13, CDL.15
- Chain h: S.377, L.381, Y.401, N.402, G.403, W.404, L.407, V.408, I.410, V.411, Q.412, I.415
- Chain s: T.8, W.9, T.64, Q.67, V.68, W.71, K.200
Ligand excluded by PLIPCDL.17: 24 residues within 4Å:- Chain 5: F.18, W.194, G.311, V.312, D.315, S.316, A.319, L.320, R.331, Y.335, R.338
- Chain P: G.53, V.54, S.55, R.57, T.58, A.61, I.62, S.65, L.66, F.69
- Ligands: CDL.18, PC1.21
- Chain e: S.432
Ligand excluded by PLIPCDL.18: 20 residues within 4Å:- Chain 5: R.196, A.319, L.320, Q.322, W.323, R.331, Y.335
- Chain J: R.19, Q.22, W.23
- Chain P: K.52, G.53, V.54, A.59, I.62, I.63
- Ligands: CDL.17, PC1.21
- Chain h: P.553
- Chain t: W.61
Ligand excluded by PLIPCDL.19: 23 residues within 4Å:- Chain G: F.62
- Chain P: M.56, R.57, W.60, I.63, G.64, T.67, L.68, L.71
- Ligands: PC1.20
- Chain e: Y.426, P.429, T.430, S.432, R.433
- Chain h: L.554, L.669
- Chain t: L.41, G.42, L.45, A.46, M.48, N.49
Ligand excluded by PLIPCDL.24: 22 residues within 4Å:- Chain S: R.23, H.24, A.25, F.26, F.31, S.33, R.34, X.39, X.40, X.41, X.42, X.43, X.45, X.46, X.47, X.49
- Chain c: W.43, M.47, G.52, R.53
- Chain l: I.515, Y.518
Ligand excluded by PLIPCDL.25: 29 residues within 4Å:- Chain 0: T.40, Y.42, Q.43, R.46
- Chain U: X.38, X.39, X.40, X.41, W.43, A.44, P.45, A.48
- Chain V: F.13
- Ligands: PC1.26, PC1.27, PC1.50
- Chain k: Y.373, F.376, I.377, L.380, F.450, I.453, I.454, I.457, L.460
- Chain l: I.15, L.18, S.19, I.22
Ligand excluded by PLIPCDL.28: 50 residues within 4Å:- Chain 1: Y.85, L.86, G.89, I.90, F.91, G.93, F.94, M.97, A.98, N.100, Y.101, T.105, V.106, W.107, W.108, P.111, W.112, F.114, P.115, M.118, A.119, A.122
- Chain C: M.32, Y.33, I.36, I.40, L.45, X.123, X.124, X.127, X.130, X.131, X.134
- Ligands: PC1.29, CDL.30, CDL.45, U10.49
- Chain f: L.12, A.15, I.16, C.19
- Chain k: M.17, L.21, M.22, K.23, Y.25, Y.102, I.106, F.129, L.136
Ligand excluded by PLIPCDL.30: 26 residues within 4Å:- Chain 1: H.99, V.110, W.112, R.113, M.116, W.117, A.120, G.123, V.124
- Chain 9: L.12, W.57, F.61
- Chain C: N.113, F.114, X.117, X.121
- Ligands: CDL.28, CDL.37
- Chain e: T.330, H.331
- Chain f: C.19, A.22, L.23, R.25, W.26
- Chain g: L.18
Ligand excluded by PLIPCDL.32: 23 residues within 4Å:- Chain 7: K.295, A.296, F.299, S.300, R.302, W.303
- Chain L: H.154, P.155, V.156, N.210, Q.211, S.212, R.388, P.389, G.390
- Chain h: I.418
- Chain j: I.194, I.197, I.198
- Chain s: S.59, V.61, V.65, F.69
Ligand excluded by PLIPCDL.37: 18 residues within 4Å:- Chain 9: Q.4, N.5, H.6, R.11, A.53, V.54, K.56, W.57, F.61
- Chain C: F.114
- Ligands: CDL.30
- Chain f: W.26, L.30
- Chain g: I.11
- Chain i: F.39, L.41, I.66, I.67
Ligand excluded by PLIPCDL.38: 17 residues within 4Å:- Chain 9: K.32, W.36, R.40, L.62, L.64, N.65, G.66, T.69, A.70, F.71, W.72, M.73, F.76, A.80
- Ligands: CDL.7
- Chain i: Q.23, N.28
Ligand excluded by PLIPCDL.45: 53 residues within 4Å:- Chain 1: I.79, L.128, F.129, F.131, R.132, V.135, N.139, R.143
- Chain C: I.46, N.48, I.51, A.52, T.54, S.55, L.58, X.129, X.130
- Chain U: W.93, R.94, G.97, Q.100, Q.101
- Ligands: CDL.28, PC1.46
- Chain i: I.56, Y.265, N.266, Y.269, Y.270, Y.273, I.276, S.277, I.280
- Chain k: L.60, I.61, I.62, G.63, Y.64, I.66, I.110, I.113, I.120, I.121, T.122, S.124, L.125, I.126, F.129, Y.172, M.175, Y.176, Y.179, S.185
Ligand excluded by PLIPCDL.51: 40 residues within 4Å:- Chain 8: A.80, G.83, A.84, Y.87, F.88, H.89, F.91, L.92, T.113, Y.115, E.116
- Chain X: K.100, Y.101, L.103, G.104, A.105, C.108, F.109, F.112, N.113, I.116
- Ligands: PC1.33, PC1.34, PC1.35, PC1.36, 3PE.54, CDL.55
- Chain l: W.230, L.236, G.237, I.284, L.285, I.288, L.289, I.292, L.296, Y.416, L.537, Y.538, I.539
Ligand excluded by PLIPCDL.55: 53 residues within 4Å:- Chain 8: M.24, R.74, G.77, R.78, M.81
- Chain X: K.100, L.103, G.104, L.107, C.108, I.111, F.112, L.115
- Chain Y: W.102
- Ligands: CDL.51, CDL.64
- Chain l: L.287, I.288, G.291, I.292, L.295, L.296, F.299, S.300, I.302, N.303, M.324, S.414, Y.416, I.420, L.422, L.423, F.424, I.426, T.526, L.527, I.529, F.530, N.531, I.532, H.533, N.534, N.535, L.537, Y.538
- Chain y: V.200, G.203, T.204, A.206, V.207, S.208, F.213, F.217
Ligand excluded by PLIPCDL.64: 28 residues within 4Å:- Chain 8: F.14, P.15, W.16, T.17, N.19, S.20, Y.23, M.24
- Ligands: CDL.55
- Chain l: F.299, I.302, L.430, L.512, L.516, Y.519, Y.521, Y.523, H.525, T.526, L.527
- Chain y: L.4, I.7, S.8, K.10, Y.11, F.15, F.213, M.216
Ligand excluded by PLIP- 1 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
NDP.8: 30 residues within 4Å:- Chain L: G.123, N.125, G.126, F.127, L.128, G.129, R.148, N.151, R.161, Y.180, P.182, C.201, I.202, G.203, G.204, F.215, L.220, F.221, L.224, T.243, S.244, H.245, I.246, K.260, P.279, A.280, D.281, I.282, D.287, N.288
15 PLIP interactions:15 interactions with chain L- Hydrogen bonds: L:N.125, L:G.126, L:F.127, L:L.128, L:G.129, L:N.151, L:I.202, L:G.203, L:K.260, L:I.282, L:D.287, L:N.288
- Salt bridges: L:R.148, L:R.161
- pi-Cation interactions: L:R.148
- 2 x ZMP: S-[2-({N-[(2S)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl}amino)ethyl] tetradecanethioate(Covalent)
ZMP.11: 26 residues within 4Å:- Chain I: I.61, R.62, L.68, L.81, I.92, R.95, F.96, E.97, Q.98, G.99, P.100, K.101, L.102, R.111, V.115, D.118, L.119, Y.122, F.127, V.132, Y.136, N.137
- Chain M: D.90, S.91, L.92
- Chain p: Q.50
16 PLIP interactions:15 interactions with chain I, 1 interactions with chain M- Hydrophobic interactions: I:I.92, I:R.95, I:F.96, I:F.96, I:V.115, I:D.118, I:L.119, I:Y.122, I:V.132, I:Y.136, I:Y.136, M:L.92
- Hydrogen bonds: I:E.97, I:L.102, I:R.111
- Salt bridges: I:R.62
ZMP.12: 22 residues within 4Å:- Chain 8: F.37
- Chain N: D.90, S.91, L.92
- Chain Y: V.39, A.46, V.49, I.50, V.71, E.74, I.75, Q.76, N.78, A.79, A.81, K.86, L.89, L.90, F.93, H.96, I.97, R.100
17 PLIP interactions:14 interactions with chain Y, 1 interactions with chain 8, 2 interactions with chain N- Hydrophobic interactions: Y:A.46, Y:V.49, Y:I.50, Y:I.50, Y:V.71, Y:V.71, Y:E.74, Y:K.86, Y:L.89, Y:F.93, Y:F.93, Y:H.96, 8:F.37, N:L.92
- Hydrogen bonds: Y:N.78, Y:A.81, N:S.91
- 4 x 3PE: 1,2-Distearoyl-sn-glycerophosphoethanolamine(Non-covalent)
3PE.23: 29 residues within 4Å:- Chain Q: P.155, Q.156, V.159, L.160, I.198, A.201, A.202, V.205, R.209
- Ligands: PC1.22, 3PE.48
- Chain k: I.166, L.170, I.208, I.212, M.216, F.223, Y.268, F.272
- Chain l: Y.570, L.571, I.573, N.575, I.576, I.577, F.579, L.580, L.583, I.584
9 PLIP interactions:7 interactions with chain l, 2 interactions with chain k- Hydrophobic interactions: l:I.573, l:I.576, l:I.577, l:F.579, l:F.579, l:L.580, l:L.583, k:I.166, k:I.212
3PE.40: 33 residues within 4Å:- Chain 0: G.1, R.5
- Chain T: K.83, Y.85
- Chain e: L.210, V.237, G.239, A.240, I.254, I.255, G.256, S.257, V.272, V.273, G.274, A.275, V.290, V.292, G.293, L.299, R.300, E.313
- Chain f: R.108, I.111, S.132, M.149, E.150, V.165, T.167, E.168, V.181, P.182, K.184
11 PLIP interactions:5 interactions with chain f, 5 interactions with chain e, 1 interactions with chain T- Hydrophobic interactions: f:I.111, f:V.165, f:V.181, f:P.182, e:L.210, e:V.290, e:V.292, e:V.292, e:L.299
- Salt bridges: f:K.184, T:K.83
3PE.48: 25 residues within 4Å:- Chain C: F.57, I.61, F.64, F.70, I.73, M.74
- Chain Q: V.216, S.217, Y.220
- Ligands: 3PE.23
- Chain k: I.166, L.169, L.170, N.173, I.201, L.202, N.204, Y.205, I.208, N.209, Y.265, Y.268
- Chain l: I.577, L.580, I.584
16 PLIP interactions:6 interactions with chain k, 2 interactions with chain l, 4 interactions with chain C, 4 interactions with chain Q- Hydrophobic interactions: k:I.166, k:L.169, l:L.580, l:I.584, C:F.64, C:F.64, C:F.70, C:F.70, Q:V.216, Q:Y.220
- Hydrogen bonds: k:N.204, k:Y.265, k:Y.265, k:Y.268, Q:Y.220, Q:Y.220
3PE.54: 37 residues within 4Å:- Chain X: A.82, M.83, D.84
- Chain Y: I.23
- Ligands: PC1.33, CDL.51
- Chain k: I.281, I.285, F.288, Y.289, F.414, I.417, L.418, S.421, L.424, Y.428
- Chain l: E.163, K.166, A.167, L.169, K.170, V.173, Y.174, I.177, I.227, W.230, G.237, F.238, D.244, E.247, D.540, L.543, S.544, M.547, F.550, S.551, I.554
20 PLIP interactions:15 interactions with chain l, 4 interactions with chain k, 1 interactions with chain X- Hydrophobic interactions: l:L.169, l:Y.174, l:Y.174, l:W.230, l:W.230, l:F.238, l:F.238, l:L.543, l:L.543, l:F.550, l:F.550, k:F.288, k:I.417, k:L.418, k:Y.428
- Hydrogen bonds: l:D.244, l:S.544, X:D.84
- Salt bridges: l:K.166, l:K.170
- 1 x U10: UBIQUINONE-10(Non-covalent)
U10.49: 29 residues within 4Å:- Chain 0: R.45, E.49, W.50, S.51, V.54
- Chain C: N.27
- Chain T: R.91
- Chain U: P.10, P.11, S.12, K.13, H.15, P.16, K.20, Y.22, R.24
- Ligands: CDL.28
- Chain e: S.319
- Chain k: Q.20, Y.25, N.26, R.93, Y.94, Y.95, N.99, T.101, Y.102, I.356, F.448
12 PLIP interactions:6 interactions with chain k, 6 interactions with chain U- Hydrophobic interactions: k:Y.25, k:Y.94, k:Y.95, U:P.10, U:P.11, U:K.13, U:P.16, U:Y.22, U:Y.22
- Hydrogen bonds: k:N.99, k:T.101
- pi-Stacking: k:Y.25
- 2 x ZN: ZINC ION(Non-covalent)
ZN.56: 6 residues within 4Å:- Chain r: C.88, G.90, H.100, C.115, C.118, N.120
4 PLIP interactions:4 interactions with chain r- Metal complexes: r:C.88, r:H.100, r:C.115, r:C.118
ZN.65: 5 residues within 4Å:- Chain y: A.59, C.61, H.62, H.66, C.164
4 PLIP interactions:4 interactions with chain y- Metal complexes: y:C.61, y:H.62, y:H.66, y:C.164
- 1 x FMN: FLAVIN MONONUCLEOTIDE(Non-covalent)
FMN.60: 23 residues within 4Å:- Ligands: NAI.62
- Chain w: G.86, R.87, G.88, A.90, K.97, N.117, D.119, E.120, S.121, D.128, Y.205, I.206, G.208, E.209, E.210, V.243, T.244, N.245, T.248, C.426, A.427, L.428
15 PLIP interactions:15 interactions with chain w- Hydrophobic interactions: w:Y.205, w:I.206, w:E.209, w:A.427, w:L.428
- Hydrogen bonds: w:R.87, w:G.88, w:N.117, w:N.117, w:D.119, w:S.121, w:E.210, w:N.245, w:T.248
- Salt bridges: w:K.97
- 1 x NAI: 1,4-DIHYDRONICOTINAMIDE ADENINE DINUCLEOTIDE(Non-covalent)
NAI.62: 21 residues within 4Å:- Ligands: FMN.60
- Chain w: G.88, G.89, A.90, F.92, K.97, F.100, E.120, S.121, E.122, T.125, Y.205, E.209, E.210, K.227, F.230, P.231, G.351, T.352, A.427, W.434
9 PLIP interactions:9 interactions with chain w- Hydrophobic interactions: w:E.122, w:Y.205, w:T.352
- Hydrogen bonds: w:G.88, w:K.97, w:S.121, w:E.122, w:E.210, w:K.227
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- He, Z. et al., Euglena's atypical respiratory chain adapts to the discoidal cristae and flexible metabolism. Nat Commun (2024)
- Release Date
- 2024-02-28
- Peptides
- NDUFS1A: A
NDUFS1B: B
ND2B: C
ND4L: D
NDUFA1: E
NDUFA2: F
NDUFA3: G
NDUFA5: H
NDUFA6: I
NDUFA7: J
NDUFA8: K
NDUFA9: L
NDUFAB1-alpha: M
NDUFAB1-beta: N
NDUFA12: O
NDUFA13: P
NDUFA11: Q
NDUFB2: R
NDUFB3: S
NDUFB4: T
NDUFB5: U
NDUFB6: V
NDUFB7: W
NDUFB8: X
NDUFB9: Y
NDUFB10: Z
NDUFB11: 0
NDUFC2: 1
NDUEG1: 2
NDUEG2: 3
NDUEG3: 4
NDUEG4: 5
NDUEG5: 6
NDUEG6: 7
NDUEG8: 8
NDUEG10: 9
NDUEG11: a
NDUEG12: b
NDUEG13: c
NDUFX: d
NDUCA1: e
NDUCA2: f
NDUCA3: g
ND1: h
ND2A: i
ND3: jm
NADH-ubiquinone oxidoreductase chain 4: k
ND5: l
NDUFS2: n
NDUFS3: o
NDUFS4: p
NDUFS5: q
NDUFS6: r
NDUFS7: s
NDUFS8: t
UNK-UNK-UNK-UNK-UNK-UNK-UNK-UNK-UNK-UNK-UNK-UNK: uv
NDUFV1: w
NDUFV2: x
NDUEG7: y - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
1AB
1BC
2BD
4LE
A1F
A2G
A3H
A5I
A6J
A7K
A8L
A9M
ABN
ACO
ALP
AMQ
ANR
B2S
B3T
B4U
B5V
B6W
B7X
B8Y
B9Z
BL0
BM1
C42
E13
E24
E35
E46
E57
E68
E89
EAa
EBb
ECc
EDd
FXe
G1f
G2g
G3h
N1i
N2j
N3m
N6k
N4l
N5n
S2o
S3p
S4q
S5r
S6s
S7t
S8u
U1v
U2w
V1x
V2y
E7 - Membrane
-
We predict this structure to be a membrane protein.
SMTL ID : 8j9j.1
Cryo-EM structure of Euglena gracilis complex I, NADH state
NDUFS1A
NDUFS1B
ND2B
ND4L
NDUFA1
NDUFA2
NDUFA3
NDUFA5
NDUFA6
NDUFA7
NDUFA8
NDUFA9
NDUFAB1-alpha
NDUFAB1-beta
NDUFA12
NDUFA13
NDUFA11
NDUFB2
NDUFB3
NDUFB4
NDUFB5
NDUFB6
NDUFB7
NDUFB8
NDUFB9
NDUFB10
NDUFB11
NDUFC2
NDUEG1
NDUEG2
NDUEG3
NDUEG4
NDUEG5
NDUEG6
NDUEG8
NDUEG10
NDUEG11
NDUEG12
NDUEG13
NDUFX
NDUCA1
NDUCA2
NDUCA3
ND1
ND2A
ND3
NADH-ubiquinone oxidoreductase chain 4
ND5
NDUFS2
NDUFS3
NDUFS4
NDUFS5
NDUFS6
NDUFS7
NDUFS8
UNK-UNK-UNK-UNK-UNK-UNK-UNK-UNK-UNK-UNK-UNK-UNK
Toggle Identical (uv)NDUFV1
NDUFV2
NDUEG7
Related Entries With Identical Sequence
2chn.1 | 2chn.2 | 5l3t.1 | 6f2r.1 | 6f2r.2 | 6f2r.3 | 6po1.1 | 6pp5.1 | 6sg9.1 | 6vzr.4 | 7fhk.1 | 7fhl.1 | 7krz.1 | 7ksm.1 | 7sxo.1 | 7y8r.1 | 8iuf.1 | 8iuf.2 | 8iuf.3 | 8iuf.13 | 8iuf.20 | 8iuf.21 | 8iuf.22 | 8iuf.23 | 8iuf.24 | 8iuf.25 | 8iuf.26 | 8iuf.27 | 8iuf.28 | 8iuf.29 more...less...8iuf.30 | 8iuf.31 | 8iuf.32 | 8iuf.33 | 8iuf.34 | 8iuf.35 | 8iuf.36 | 8iuf.37 | 8iuf.38 | 8iuf.39 | 8iuf.40 | 8iuf.41 | 8iuf.42 | 8iuf.46 | 8iuf.48 | 8iuf.51 | 8iuf.52 | 8iuf.53 | 8iuf.54 | 8iuf.55 | 8iuf.57 | 8iuf.58 | 8iuf.59 | 8iuf.60 | 8iuf.61 | 8iuf.62 | 8iuf.63 | 8iuf.64 | 8iuf.65 | 8iuf.66 | 8iuf.67 | 8iuf.68 | 8iuf.69 | 8iuf.70 | 8iuf.93 | 8iuf.94 | 8iuf.95 | 8iuf.96 | 8iuf.97 | 8iuf.98 | 8iuf.99 | 8iuf.100 | 8iuf.101 | 8j9h.1 | 8j9i.1 | 8px3.1 | 8q96.1 | 9cc0.1